BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate UpdateGlobeNewsWire • 12/30/21
BeyondSpring's New Plinabulin Data Shows Fast Onset In Preventing Chemo-Induced NeutropeniaBenzinga • 12/15/21
BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin's Fast Onset Mechanism of Action in the Prevention of Chemotherapy-Induced Neutropenia at the 63rd ASH Annual Meeting and ExpositionGlobeNewsWire • 12/15/21
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors BeyondSpring Inc. - BYSIPRNewsWire • 12/13/21
BeyondSpring Pharmaceuticals Announces Analysis of New Data on the Plinabulin/Pegfilgrastim Combination in Breast Cancer at the 2021 San Antonio Breast Cancer SymposiumGlobeNewsWire • 12/10/21
SHAREHOLDER ALERT: Investigation of BeyondSpring, Inc. Announced by Holzer & Holzer, LLCNewsfile Corp • 12/02/21
BeyondSpring's NDA for CIN treatment 'cannot be approved' in current form, FDA saysMarket Watch • 12/01/21
BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx ConferenceGlobeNewsWire • 11/24/21
BeyondSpring Announces First Patient Treated in Phase 2 Study with Plinabulin Combined with Nivolumab + Ipilimumab in Patients in 3rd Line Recurrent Small-Cell Lung Cancer Patients Who Failed Checkpoint InhibitorsGlobeNewsWire • 10/21/21
BeyondSpring Pharmaceuticals Announces New Patient-Derived Cancer Model Data for Plinabulin Monotherpy at the AACR-NCI-EORTC Virtual International Conference to Further Support the Positive Clinical Data Already Reported for the Treatment of Small Cell LuGlobeNewsWire • 10/20/21
BeyondSpring Pharmaceuticals Announces Positive Final Phase 3 DUBLIN-3 Data with the Plinabulin/Docetaxel Combination versus Docetaxel Alone in 2nd/3rd Line Non-Small Cell Lung Cancer Patients with EGFR Wild Type at the European Society for Medical OncoloGlobeNewsWire • 09/20/21
BeyondSpring Pharmaceuticals Announces New Positive Data on Plinabulin from Its Chemotherapy-Induced Neutropenia Prevention Program at the European Society for Medical Oncology 2021 CongressGlobeNewsWire • 09/16/21